Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 2Withdrawn 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Multiple Myeloma 4Recurrence 3Solid Tumor Malignancy 1Sarcoma, Ewing 1Sarcoma, Alveolar Soft Part 1Sarcoma 1Rhabdoid Tumor 1Recurrent Squamous Cell Lung Carcinoma 1Neurofibrosarcoma 1Neoplasm, Residual 1Lymphoma, Large B-Cell, Diffuse 1Liposarcoma 1Immunoglobulin Light-chain Amyloidosis 1Central Nervous System Neoplasms 1Amyloidosis 1Alzheimer Disease 1

Interventions

selinexor 1ixazomib 1Neurofibromin 1 1CPI-0610 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Neurofibrosarcoma × selinexor × Clear all
NCT03880123 2020-11-27

Selinexor in Combination With Ixazomib for the Treatment of Advanced Sarcoma

Columbia University

Phase 1 Withdrawn
Sarcoma

Liposarcoma, Sarcoma, Sarcoma, Ewing, Sarcoma, Alveolar Soft Part, Neurofibrosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡